Smoking cessation for people living with HIV/ AIDS: A literature review and synthesis

Nicotine and Tobacco Research

Volumn 18, Issue 12, 2016, Pages 2177-2184

  Ledgerwood, David M ^a   Yskes, Russell ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE; VARENICLINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BEHAVIOR THERAPY; COMMUNITY CARE; COMMUNITY PROGRAM; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL TECHNOLOGY; MORBIDITY; MORTALITY; NAMED GROUPS OF PERSONS; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; PEOPLE LIVING WITH HIV AIDS; PREVALENCE; REVIEW; SMOKING CESSATION; THERAPY EFFECT; TOBACCO DEPENDENCE; TREATMENT RESPONSE; PROCEDURES;

BEHAVIOR THERAPY; HIV INFECTIONS; HUMANS; SMOKING CESSATION;

EID: 85014096312     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntw126     Document Type: Review

References (70)

1. U.S. Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
2. World Health Organization. WHO Global Report: Mortality Attributable to Tobacco. Geneva, Switzerland: WHO; 2012.
3. Mamary EM, Bahrs D, Martinez S. Cigarette smoking and the desire to quit among individuals living with HIV. AIDS Patient Care STDS. 2002;16(1):39-42. doi:10.1089/108729102753429389.
4. Shuter J, Bernstein SL, Moadel AB. Cigarette smoking behaviors and beliefs in persons living with HIV/AIDS. Am J Health Behav. 2012;36(1):75-85. doi:10.5993/AJHB.36.1.8.
5. Tesoriero JM, Gieryic SM, Carrascal A, Lavigne HE. Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation. AIDS Behav. 2010;14(4):824-835. doi:10.1007/s10461-008-9449-2.
6. The Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372(9635):293-299 doi:10.1016/S0140-6736(08)61113-7.
7. The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349(9):1993-2003. doi:10.1056/NEJMoa030218.
8. Friis-Møller N, Weber R, Reiss P, et al.; DAD Study Group. Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. AIDS. 2003;17(8):1179-1193.
9. Zwiebel MA, Hughes V. Smoking cessation efforts in one New York City HIV clinic. J Assoc Nurses AIDS Care. 2010;21(1):11-15. doi:10.1016/j. jana.2009.10.001.
10. Burkhalter JE, Springer CM, Chhabra R, Ostroff JS, Rapkin BD. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res. 2005;7(4):511-522. doi:10.1080/14622200500186064.
11. Elzi L, Spoerl D, Voggensperger J, et al.; Swiss HIV Cohort Study. A smoking cessation program in HIV-infected individuals: a pilot study. Antivir Ther. 2006;11(6):787-795.
12. Feldman JG, Minkoff H, Schneider MF, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. Am J Public Health. 2006;96(6):1060-1065. doi:10.2105/AJPH.2005.062745.
13. Gritz ER, Vidrine DJ, Lazev AB, Amick BC, Arduino RC. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res. 2004;6:71-77. doi:10.1080/14622200310001656885.
14. Hessol NA, Weber KM, D'Souza G, et al. Smoking cessation and recidivism in the Women's Interagency Human Immunodeficiency Virus Study. Am J Prevent Med. 2014;47(1):53-69. doi:10.1016/j.amepre.2014.02.010.
15. Pacek LR, Harrell P, Martins SS. Cigarette smoking and drug use among a nationally representative sample of HIV-positive individuals. Am J Addict. 2014;23(6):582-90. doi:10.1111/j.1521-0391.2014.12145.x.
16. Grover KW, Gonzalez A, Zvolensky MJ. HIV symptom distress and smoking outcome expectancies among HIV+ smokers: a pilot test. AIDS Patient Care STDs. 2013;27(1):17-21. doi:10.1089/apc.2012.0333.
17. Peretti-Watel P, Garelik D, Baron G, Spire B, Ravaud P, Duval X; EVIT Study Group. Smoking motivations and quitting motivations among HIVinfected smokers. Antivir Ther. 2009;14(6):781-787. doi:10.3851/1292.
18. Encrenaz G, Benard A, Rondeau V, et al.; ANRS CO3 Aquitaine Study Group (Groupe d'Epidémiologie Clinique du Sida en Aquitaine). Determinants of smoking cessation attempts among HIV-infected patients: results from a hospital-based prospective cohort. Curr HIV Res. 2010;8(3):212-217. doi:10.2174/157016210791111089.
19. Crothers K, Griffith TA, McGinnis KA, et al. The impact of cigarette smoking on mortality, quality of life and comorbid illness among HIV-positive veterans. J Gen Intern Med. 2005;20(12):1142-1145. doi:10.1111/j.1525-1497.2005.0255.x.
20. Clifford GM, Polesel J, Rickenbach M, et al.; Swiss HIV Cohort. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97(6):425-432. doi:10.1093/jnci/dji072.
21. Sridhar KS, Flores MR, Raub WA, Saldana M. Lung cancer in patients with human immunodeficiency virus infection compared with historic control subjects. Chest. 1992;102(6):1704-1708.
22. Turner J, Page-Shafer K, Chin DP, et al.; Pulmonary Complications of HIV Infection Study Group. Adverse impact of cigarette smoking on dimensions of health-related quality of life in persons with HIV infection. AIDS Patient Care STDS. 2001;15(12):615-624. doi:10.1089/108729101753354617.
23. Page-Shafer K, Delorenze GN, Satariano WA, Winkelstein W. Comorbidity and survival in HIV-infected men in the San Francisco Men's Health Survey. Ann Epidemiol. 1996;6(5):420-430. doi:10.1016/S1047-2797(96)00064-6.
24. Shuter J, Bernstein SL. Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine Tob Res. 2008;10(4):731-736. doi:10.1080/14622200801908190.
25. Vidrine DJ, Arduino RC, Gritz ER. The effects of smoking abstinence on symptom burden and quality of life among persons living with HIV/AIDS. AIDS Patient Care STDS. 2007;21(9):659-666. doi:10.1089/apc.2007.0022.
26. Lifson AR, Neuhaus J, Arribas JR, van den Berg-Wolf M, Labriola AM, Read TR; INSIGHT SMART Study Group. Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial. Am J Public Health. 2010;100(10):1896-1903. doi:10.2105/AJPH.2009.188664.
27. Shirley DK, Kaner RJ, Glesby MJ. Effects of smoking on non-AIDS-related morbidity in HIV-infected patients. Clin Infect Dis. 2013;57(2):275-282. doi:10.1093/cid/cit207.
28. Jha P, Ramasundarahettige C, Landsman V, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013;368(4):341-350. doi:10.1056/NEJMsa1211128.
29. Benard A, Mercié P, Alioum A, et al. Bacterial pneumonia among HIVinfected patients: decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort, 2000-2007. PLoS One. 2010;5(1):e8896. doi:10.1371/journal.pone.0008896.
30. Fuster M, Estrada V, Fernandez-Pinilla MC, et al. Smoking cessation in HIV patients: rate of success and associated factors. HIV Med. 2009;10(10):614-619. doi:10.1111/j.1468-1293.2009.00735.x.
31. Petoumenos K, Worm S, Reiss P, et al.; D:A:D Study Group. Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*). HIV Med. 2011;12(7):412-421. doi:10.1111/j.1468-1293.2010.00901.x.
32. Horvath KJ, Eastman M, Prosser R, Goodroad B, Worthington L. Addressing smoking during medical visits: patients with Human Innunodeficiency Virus. Am J Prevent Med. 2012;43(5 suppl 3):S214-S221. doi:10.1016/j.amepre.2012.07.032.
33. Berg CJ, Nehl EJ, Wang X, et al. Healthcare provider intervention on smoking and quit attempts among HIV-positive versus HIV-negative MSM smokers in Chengdu, China. AIDS Care. 2014;26(9):1201-1207. doi:10.1080/09540121.2014.892565.
34. Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: Agency for Healthcare Research and Quality; 2008.
35. Lloyd-Richardson EE, Stanton CA, Papandonatos GD, et al. Motivation and patch treatment for HIV+ smokers: a randomized controlled trial. Addiction. 2009;104(11):1891-1900. doi:10.1111/j. 1360-0443.2009.02623.x.
36. Ingersoll KS, Cropsey KL, Heckmann CJ. A test of motivational plus nicotine replacement interventions for HIV positive smokers. AIDS Behav. 2009;13(3):545-554. doi:10.1007/s10461-007-9334-4.
37. Cropsey KL, Hendricks PS, Jardin B, et al. A pilot study of screening, brief intervention, and referral for treatment (SBIRT) in non-treatment seeking smokers with HIV. Addict Behav. 2013;38(10):2541-2546. doi:10.1016/j. addbeh.2013.05.003.
38. Manuel JK, Lum PJ, Hengl NS, Sorensen JL. Smoking cessation interventions with female smokers living with HIV/AIDS: a randomized pilot study of motivational interviewing. AIDS Care. 2013;25(7):820-827. doi: 10.1080/09540121.2012.733331.
39. Moadel AB, Bernstein SL, Mermelstein RJ, Arnsten JH, Dolce EH, Shuter J. A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers. J Acquir Immune Defic Syndr. 2012;61(2):208-215. doi:10.1097/QAI.0b013e3182645679.
40. Cummins D, Trotter G, Moussa M, Turham G. Smoking cessation for clients who are HIV-positive. Nurs Stand. 2005;20(12):41-47.
41. Wewers ME, Neidig JL, Kihm KE. The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIV-positive smokers. J Assoc Nurses AIDS care. 2000;11(6):37-44. doi:10.1016/S1055-3290(06)60353-1.
42. Matthews AK, Conrad M, Kuhns L, Vargas M, King AC. Project exhale: preliminary evaluation of a tailored smoking cessation treatment for HIV-positive African American smokers. AIDS Patient Care STDs. 2013;27(1):22-32. doi:10.1089/apc.2012.0253.
43. Browning KK, Wewers ME, Ferketich AK, Diaz P, Koletar SL, Reynolds NR. Adherence to Tobacco Dependence Treatment Among HIVInfected Smokers. AIDS Behav. 2016;20(3):608-621. doi:10.1007/s10461-015-1059-1.
44. Chew D, Steinberg MB, Thomas P, Swaminathan S, Hodder SL. Evaluation of a smoking cessation program for HIV infected individuals in an urban HIV clinic: challenges and lessons learned. AIDS Res Treat. 2014:1-8. doi:10.1155/2014/237834.
45. Cropsey KL, Jardin BF, Burkholder GA, Clark CB, Raper JL, Saag MS. An algorithm approach to determining smoking cessation treatment for persons living with HIV/AIDS: results of a pilot trial. J Acquir Immune Defic Syndr. 2015;69(3), 291-298. doi:10.1097/QAI.0000000000000579.
46. Huber M, Ledergerber B, Sauter R, et al.; Swiss HIV Cohort Study Group. Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians. HIV Med. 2012;13(7):387-397. doi:10.1111/j.1468-1293.2011.00984.x.
47. Chander G, Stanton C, Hutton HE, et al. Are smokers with HIV using information and communication technology? Implications for behavioral interventions. AIDS Behav. 2012;16(2):383-388. doi:10.1007/s10461-011-9914-1.
48. Lazev AB, Vidrine DJ, Arduino RC, Gritz ER. Increasing access to smoking cessation treatment in low-income, HIV-positive population: the feasibility of using cellular telephones. Nicotine Tob Res. 2004;6(2):281-286. doi:10.1080/14622200410001676314.
49. Gritz ER, Danysh HE, Fletcher FE, et al. Long-term outcomes of a cell phone-delivered intervention for smokers living with HIV/AIDS. Clin Infect Dis. 2013;57(4):608-615. doi:10.1093/cid/cit349.
50. Vidrine DJ, Arduino RC, Gritz ER. Impact of a cell phone intervention on mediating mechanisms of smoking cessation in individual living with HIV/AIDS. Nicotine Tob Res. 2006;8(suppl 1):S103-S108. doi:10.1080/14622200601039451.
51. Vidrine DJ, Marks RM, Arduino RC, Gritz ER. Efficacy of cell phonedelivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes. Nicotine Tob Res. 2012;14(1):106-110. doi:10.1093/ntr/ntr121.
52. Shuter J, Morales DA, Considine-Dunn SE, An LC, Stanton CA. Feasibility and preliminary efficacy of a web-based smoking cessation intervention for HIV-infected smokers: a randomized controlled trial. J Acquir Immune Defic Syndr. 2014;67(1):59-66. doi:10.1097/QAI.0000000000000226.
53. Humfleet GL, Hall SM, Delucchi KL, Dilleay JW. A randomized clinical trial of smoking cessation treatments provided in HIV clinical are settings. Nicotine Tob Res. 2013;15(8):1436-1445. doi:10.1093/ntr/ntr121.
54. Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis (review). Cochrane Database Syst Rev. 2013;5:CD009329. doi:10.1002/14651858.
55. Stanton CA, Lloyd-Richardson EE, Papandonatos GD, de Dios MA, Niaura R. Mediators of the relationship between nicotine replacement therapy and smoking abstinence among people living with HIV/AIDS. AIDS Educ Prev. 2009;21(3 suppl):65-80. doi:10.1521/aeap.2009.21.3_supp.65.
56. Currier MB, Molina G, Kato M. A prospective trial of sustained-release bupropion for depression in HIV-seropositive and AIDS patients. Psychosomatics. 2003;44(2):120-125.
57. Hesse LM, Greenblatt DJ, von Moltke LL, Court MH. Ritonavir has minimal impact on the pharmacokinetic disposition of a single dose of bupropion administered to human volunteers. J Clin Pharmacol. 2006;46(5):567-576. doi:10.1177/0091270006286981.
58. Park J, Vousden M, Brittain C, et al. Dose-related reductions in bupropion plasma concentrations by ritonavir. J Clin Pharmacol. 2010;50(10):1180-1187. doi:10.1177/0091270009359524.
59. Hogeland GW, Swindells S, McNabb JC, Kashuba ADM, Yee GC, Lindley CM. Lopinavir/ritonavir reduces bupropion plasma concentrations in healthy subjects. Clin Pharm Ther. 2006;81(1):69-75. doi:10.1038/sj.clpt.6100027.
60. Robertson SM, Maldarelli F, Natarajan V, Formentini E, Alfaro RM, Penzak SR. Efavirenz induces CYP2B6-mediated hydroxylation of bupropion in healthy subjects. J Acquir Immune Defic Syndr. 2008;49(5):513-519 doi:10.1097/QAI.0b013e318183a425.
61. Jorenby DE, Hays JT, Rigotti NA, et al.; Varenicline Phase 3 Study Group. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006;296(11):56-63. doi:10.1001/jama.296.1.56.
62. Cui Q, Robinson L, Elston D, et al. Safety and tolerability of varenicline tartrate (Champix/Chantix) for smoking cessation in HIV-infected subjects: a pilot open-label study. AIDS Patient Care STDs. 2012;26(1):12-19 doi:10.1089/apc.2011.0199.
63. Ferketich AK, Diaz P, Browning KK, et al. Safety of varenicline among smokers enrolled in the Lung HIV study. Nicotine Tob Res. 2013;15(1):247-254. doi:10.1093/ntr/nts121.
64. Tornero C, Mafé C. Varenicline and antiretroviral therapy in patients with HIV. J Acquir Immune Defic Syndr. 2009;52(2):656. doi:10.1097/QAI.0b013e3181ba1beb.
65. Heckman CJ, Egleston BL, Hofmann MT. Efficacy of motivational interviewing for smoking cessation: a systematic review and meta-analysis. Tob Control. 2010;19(5):410-416. doi:10.1136/tc.2009.033175.
66. Mottillo S, Filion KB, Bélisle P, et al. Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials. Eur Heart J. 2009;30(6):718-730. doi:10.1093/eurheartj/ehn552.
67. Ledgerwood DM. Contingency management for smoking cessation: where do we go from here? Curr Subst Abuse Rev. 2008;1(6):340-349. doi:10.2 174/1874473710801030340.
68. Petry NM, Martin B, Finocche C. Contingency management in group treatment: a demonstration project in an HIV drop-in center. J Subst Abuse Treat. 2001;21(2):89-96. doi:10.1016/S0740-5472(01)00184-2.
69. Rosen MI, Dieckhaus K, McMahon TJ, et al. Improved adherence with contingency management. AIDS Patient Care STDS. 2007;21(1):30-40. doi:10.1089/apc.2006.0028.
70. Crothers K, Goulet JL, Rodriguez-Barraas MC, et al. Decreased awareness of current smoking among health care providers of HIV-positive compared to HIV-negative veterans. J Gen Intern Med. 2007;22(6):749-754. doi:10.1007/s11606-007-0158-8.